| Description | Pipratecol can affect platelet aggregation and the platelet release reaction. |
| molecular weight | 344.4 |
| Molecular formula | C19H24N2O4 |
| CAS | 15534-05-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Cattaneo M, D'Angelo A, Mannucci PM, Pareti F, Vanasia S, Viganò. [Effect of raubasine and pipratecol on platelet aggregation and on the platelet release reaction]. Clin Ter. 1980 Feb 29;92(4):359-68. Italian. PubMed PMID: 6108818. 2. Passero S, Battistini N. Effect of a Raubasine-Pipratecol association (Isosarpan) on the sympathetic control of cerebral circulation. Acta Neurol (Napoli). 1979 Feb;1(1):45-58. PubMed PMID: 433680. 3. Laubie M, Le Douarec JC. [Pharmacological study of pipratecol (JP 711) and of a pharmaceutical combination raubasine-JP 711]. Arzneimittelforschung. 1969 Nov;19(11):1820-6. French. PubMed PMID: 4391788. 4. Beil W, Staar U, Sewing KF. Substituted thieno[3,4-d]imidazoles, a novel group of H+/K(+)-ATPase inhibitors. Differentiation of their inhibition characteristics from those of omeprazole. Eur J Pharmacol. 1990 Oct 23;187(3):455-67. PubMed PMID: 1963594. |